Dempze Nancy E Stryker Corp Transaction History

Dempze Nancy E

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$194.09 - $276.37 $340,627 - $485,029	-1,755 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$236.63 - $276.44 $14,197 - $16,586	-60 Reduced 3.31%	1,755 $469,000
Q3 2021 Nov 10, 2021	SELL	$248.9 - $280.09 $12,445 - $14,004	-50 Reduced 2.68%	1,815 $479,000
Q2 2021 Aug 09, 2021	BUY	$242.95 - $267.0 $27,939 - $30,705	115 Added 6.57%	1,865 $484,000
Q1 2020 May 07, 2020	SELL	$126.5 - $225.1 $6,325 - $11,255	-50 Reduced 2.78%	1,750 $291,000
Q4 2019 Jan 15, 2020	SELL	$197.98 - $220.53 $9,899 - $11,026	-50 Reduced 2.7%	1,800 $378,000
Q1 2018 Apr 24, 2018	SELL	$148.01 - $168.91 $148,010 - $168,910	-1,000 Reduced 35.09%	1,850 $298,000
Q3 2017 Oct 26, 2017	BUY	$138.36 - $147.87 $394,326 - $421,429	2,850	2,850 $405,000

2,228

285M

1.35M

1.6M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $146B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Dempze Nancy E, based on Form 13F filings with the SEC.

Stay updated on Dempze Nancy E with notifications on news.